TACROLIMUS
Generic: TACROLIMUS
TACROLIMUS is FDA application ANDA200744, sponsored by FOUGERA PHARMS INC. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Presence of foreign tablet/capsule - Potential presence of commingled one Tacrolimus 1 mg capsule in
Presence of Foreign Tablets/Capsules: Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle
Failed Moisture Limits
Failed USP Content Uniformity Requirements: OOS result reported on retained samples.
Defective Container: Tube split from side seam
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrol
Cross Contamination with Other Products: findings of carryover of trace amounts of a previously manu